Publications by authors named "Steven Swendeman"

Claim this Profile
D
Designer high-density lipoprotein particles enhance endothelial barrier function and suppress inflammation.
Yueh-Chien Lin, Steven Swendeman, Irina S Moreira, Avishek Ghosh, Andrew Kuo

Sci Signal· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Therapeutic activation of endothelial sphingosine-1-phosphate receptor 1 by chaperone-bound S1P suppresses proliferative retinal neovascularization.
Colin Niaudet, Bongnam Jung, Andrew Kuo, Steven Swendeman, Edward Bull

EMBO Mol Med· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Plasma components to protect the endothelial barrier after shock: A role for sphingosine 1-phosphate.
Lawrence N Diebel, David M Liberati, Timothy Hla, Steven Swendeman

Surgery· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sphingosine 1-Phosphate Receptor Signaling Establishes AP-1 Gradients to Allow for Retinal Endothelial Cell Specialization.
Keisuke Yanagida, Eric Engelbrecht, Colin Niaudet, Bongnam Jung, Konstantin Gaengel, Steven Swendeman

Dev Cell· March 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Identification of ApoA4 as a sphingosine 1-phosphate chaperone in ApoM- and albumin-deficient mice.
Hideru Obinata, Andrew Kuo, Yukata Wada, Steven Swendeman, Catherine H Liu

J Lipid Res· November 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Lipid Mediators, M2 Macrophages, and Pathological Neovascularization.
Steven L Swendeman, Timothy Hla

Trends Mol Med· December 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sphingosine 1-Phosphate Receptor 1 Signaling Maintains Endothelial Cell Barrier Function and Protects Against Immune Complex-Induced Vascular Injury.
Nathalie Burg, Steven Swendeman, Stefan Worgall, Timothy Hla, Jane E Salmon

Arthritis Rheumatol· November 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
An engineered S1P chaperone attenuates hypertension and ischemic injury.
Steven L Swendeman, Yuquan Xiong, Anna Cantalupo, Hui Yuan, Nathalie Burg

Sci Signal· August 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Characterization of the catalytic properties of the membrane-anchored metalloproteinase ADAM9 in cell-based assays.
Thorsten Maretzky, Steven Swendeman, Elin Mogollon, Gisela Weskamp, Umut Sahin

Biochem J· April 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
HDL activation of endothelial sphingosine-1-phosphate receptor-1 (S1P) promotes regeneration and suppresses fibrosis in the liver.
Bi-Sen Ding, Catherine H Liu, Yue Sun, Yutian Chen, Steven L Swendeman

JCI Insight· December 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impaired endothelial barrier function in apolipoprotein M-deficient mice is dependent on sphingosine-1-phosphate receptor 1.
Pernille M Christensen, Catherine H Liu, Steven L Swendeman, Hideru Obinata, Klaus Qvortrup

FASEB J· June 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
HDL-bound sphingosine 1-phosphate acts as a biased agonist for the endothelial cell receptor S1P1 to limit vascular inflammation.
Sylvain Galvani, Marie Sanson, Victoria A Blaho, Steven L Swendeman, Hideru Obinata

Sci Signal· August 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
HDL-bound sphingosine-1-phosphate restrains lymphopoiesis and neuroinflammation.
Victoria A Blaho, Sylvain Galvani, Eric Engelbrecht, Catherine Liu, Steven L Swendeman

Nature· July 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
iRHOM2 is a critical pathogenic mediator of inflammatory arthritis.
Priya Darshinee A Issuree, Thorsten Maretzky, David R McIlwain, Sébastien Monette, Xiaoping Qing, Steven L Swendeman

J Clin Invest· February 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Intravitreal injection of TIMP3 or the EGFR inhibitor erlotinib offers protection from oxygen-induced retinopathy in mice.
Nina Jasmin Hewing, Gisela Weskamp, Joost Vermaat, Eric Farage, Krzysztof Glomski, Steven Swendeman

Invest Ophthalmol Vis Sci· January 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Migration of growth factor-stimulated epithelial and endothelial cells depends on EGFR transactivation by ADAM17.
Thorsten Maretzky, Astrid Evers, Wenhui Zhou, Steven L Swendeman, Pui-Mun Wong

Nat Commun· August 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Stimulation of platelet-derived growth factor receptor beta (PDGFRbeta) activates ADAM17 and promotes metalloproteinase-dependent cross-talk between the PDGFRbeta and epidermal growth factor receptor (EGFR) signaling pathways.
Karen Mendelson, Steven Swendeman, Paul Saftig, Carl P Blobel

J Biol Chem· August 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
ADAM8 is a negative regulator of retinal neovascularization and of the growth of heterotopically injected tumor cells in mice.
Victor H Guaiquil, Steven Swendeman, Wenhui Zhou, Patricio Guaiquil, Gisela Weskamp

J Mol Med (Berl)· May 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
ADAM9 is involved in pathological retinal neovascularization.
Victor Guaiquil, Steven Swendeman, Tsunehiko Yoshida, Sai Chavala, Peter A Campochiaro

Mol Cell Biol· May 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Loss of the metalloprotease ADAM9 leads to cone-rod dystrophy in humans and retinal degeneration in mice.
David A Parry, Carmel Toomes, Lina Bida, Michael Danciger, Katherine V Towns, Steven Swendeman

Am J Hum Genet· May 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
VEGF-A stimulates ADAM17-dependent shedding of VEGFR2 and crosstalk between VEGFR2 and ERK signaling.
Steven Swendeman, Karen Mendelson, Gisela Weskamp, Keisuke Horiuchi, Urban Deutsch

Circ Res· October 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
ADAM10 is a principal 'sheddase' of the low-affinity immunoglobulin E receptor CD23.
Gisela Weskamp, Jill W Ford, Jamie Sturgill, Steve Martin, Andrew J P Docherty, Steven Swendeman

Nat Immunol· December 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A neurotrophin axis in myeloma: TrkB and BDNF promote tumor-cell survival.
Roger N Pearse, Steven L Swendeman, Ying Li, Dahlia Rafii, Barbara L Hempstead

Blood· June 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis